Physician
Oncology
Dr. Chad Pecot, MD
|
|
Give Review
Chad Pecot practices Oncology. He attended University of Miami Miller School of Medicine. University of Miami Miller School of Medicine is ranked 45/0 in Research/PrimaryCare. Chad Pecot is a published doctor. He published 21 publications, including: 'Erythropoietin Stimulates Tumor Growth via EphB4.' Chad Pecot, MD accepts all Medicare patients.
Publications
- Erythropoietin Stimulates Tumor Growth via EphB4.
- Functional proteomics identifies miRNAs to target a p27/Myc/phospho-Rb signature in breast and ovarian Cancer.
- Differential platelet levels affect response to taxane-based therapy in ovarian Cancer.
- Copy Number Gain of hsa-miR-569 at 3q26.2 Leads to Loss of TP53INP1 and Aggressiveness of Epithelial Cancers.
- Therapeutic Silencing of KRAS using Systemically Delivered siRNAs.
- Hematogenous metastasis of ovarian Cancer: rethinking mode of spread.
- Antagonism of Tumoral Prolactin Receptor Promotes Autophagy-Related Cell Death.
- Notch3 Pathway Alterations in Ovarian Cancer.
- Crosstalk between EphA2 and BRaf/CRaf is a Key Determinant of Response to Dasatinib.
- Systematic identification of molecular subtype-selective vulnerabilities in non-small-cell Lung cancer.
- Role of Focal Adhesion Kinase in Regulating YB-1-Mediated Paclitaxel Resistance in Ovarian Cancer.
- Tumour angiogenesis regulation by the miR-200 family.
- Therapeutic Synergy between microRNA and siRNA in Ovarian Cancer Treatment.
- Integrated Analyses Identify a Master MicroRNA Regulatory Network for the Mesenchymal Subtype in Serous Ovarian Cancer.
- 2'-OMe-phosphorodithioate-modified siRNAs show increased loading into the RISC complex and enhanced anti-tumour activity.
- Paraneoplastic thrombocytosis in ovarian Cancer.
- Targeted delivery of small interfering RNA using reconstituted high-density lipoprotein nanoparticles.
- RNA interference in the clinic: challenges and future directions.
- Diagnostic characteristics of a serum biomarker in patients with positron emission tomography scans.
- A very late stent thrombosis in a patient with diabetes: a call for lifelong dual anti-platelet therapy.
Schools
University of Miami School of Medicine
Conditions Treated
- Lung Cancer
- Melanoma
- Non-Hodgkin's Lymphoma
- Secondary Malignancies
- View All
Doctors Specialties
- Medical Oncology
- Oncology
Accepted Insurances
Education
-
University of Texas Health Science Center -
Vanderbilt University -
University of Miami Miller School of Medicine
Drug Facts
| NPI NUMBER | 1033266994 | |
| NPPES Provider LastName | PECOT | |
| NPPES Provider FirstName | CHAD | |
| NPPES Provider ZIPCode | 770304000 | |
| NPPES Provider State | TX | |
| Specialty Description | Medical Oncology | |
| Total Claim Count | 17.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1033266994 |
| Last Name Of The Provider | PECOT |
| First Name Of The Provider | CHAD |
| View All |
Similar Doctors
|
|
Dr. Paolo Anderlini, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rachna Shroff, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Katherine M. Pisters, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Joan M. Bull, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Padmanee Sharma, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jaffer A. Ajani, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. An N. Hoang, MD |
|
|
Dr. Martin J. Hrgovcic, MD |
|
|
Michael Wang |